6620 TWO Week ended 14 Aug 2026

Weekly Investor Report

Handa Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 77.40 TWD
-8.4% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is -1.3% below the Trend Line and sits at 16.6% of its 52-week range. The latest completed week returned -8.4%, after a -10.5% four-week move. Near-term considerations: volume confirmation is below normal.

Setup score 27 out of 100
Latest Close 77.40 TWD 14 Aug 2026
1W Return -8.4% latest completed week
4W Return -10.5% short-term follow-through
12W Return 4.8% quarterly tape
Trend Breadth 44.2% 23 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • The trend backdrop is active with a 4-week active streak.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 41.33% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -8.4% Latest completed week; four-week move -10.5%. Indicator stack 38/58 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 41.33% Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -1.3% below the Trend Line and sits at 16.6% of its 52-week range. The latest completed week returned -8.4%, after a -10.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3212-week average 0.15

12-week confirmation

Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.32Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.5% over four weeks, 4.8% over 12 weeks, and -3.5% over one year. The current trend has remained active for 4 consecutive weeks.

Performance by holding period

1W-8.4%
4W-10.5%
12W4.8%
26W1.9%
52W-3.5%
Active trend streak4 weeks
Active weeks in one year23
Trend breadth44.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.68Latest activity-pressure read.
Pressure change-54.9%Four-week change in activity pressure.
Leadership-40.66Latest relative-leadership reading.
RS change-28.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment-

No current sentiment snapshot is stored.

Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-48.7%Distance below the 52-week high.
13-week volatility9.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+20.3%Week of 19 Jun.
Worst week-13.1%Week of 17 Jul.
Latest week-8.4%Week of 14 Aug.

Shape of recent returns

Strong gains8
Modest gains0
Flat weeks0
Modest losses11
Sharp losses7
Recent vol9.1%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split18/33Count of positive and negative weeks in the 52-week window.
Average skew9.0% / -4.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis43/100

Latest 12-week confirmation: trend 4/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.32; No reversal markers Next-Week ExpectancyNegative 41.33%

Next-week expectancy is negative with a 41.33% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Sentiment50/100

No sentiment snapshot is stored yet.

 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
14 Aug 202677.40 TWD-8.4%78.45 TWD101.8 TWD0.68-40.663.4MOn
7 Aug 202684.50 TWD-3.9%78.66 TWD102.3 TWD0.97-33.633.7MOn
31 Jul 202687.90 TWD4.4%78.63 TWD102.7 TWD1.19-29.919.2MOn
24 Jul 202684.20 TWD-2.7%78.59 TWD103.2 TWD1.23-34.352.1MOn
17 Jul 202686.50 TWD-13.1%79.01 TWD103.7 TWD1.50-31.675.8MOff
10 Jul 202699.50 TWD-0.9%79.37 TWD104.2 TWD1.50-26.793.5MOff
3 Jul 2026100.4 TWD9.4%79.51 TWD104.6 TWD1.14-28.972.9MOff
26 Jun 202691.80 TWD14.5%80.07 TWD105.0 TWD0.77-32.439.6MOff
19 Jun 202680.14 TWD20.3%80.80 TWD105.4 TWD0.42-43.913.6MOff
12 Jun 202666.62 TWD-4.0%82.05 TWD105.9 TWD0.23-51.572.9MOff
5 Jun 202669.37 TWD-1.7%83.84 TWD106.4 TWD0.20-51.241.6MOff
29 May 202670.54 TWD-4.5%85.64 TWD107.0 TWD0.21-50.702.0MOff
22 May 202673.87 TWD7.7%87.36 TWD107.5 TWD0.15-46.092.7MOff
15 May 202668.58 TWD-1.0%89.32 TWD108.1 TWD0.16-49.202.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context